Clinical Evidence

Amazing things happen when you dab the Dynamiclear Antiviral Gel onto a lesion. The antiviral actives in Dynamiclear destroy the active infection on contact and this sets into motion super fast healing of symptoms.

Dynamiclear 'dries out' blisters and wounds, relieves itching, redness, pain and burning, and often kick-starts the scabbing stage (or closing over of the wound) within several hours instead of days.

University Clinical Trial Evidence

In an independent, peer-reviewed and published University clinical trial, it was demonstrated that the Dynamiclear active (Cupric ions) reduced colony forming HSV cells from 100% to less than 1.0% in under an hour. That means an unprecedented 99.0% of the virus was destroyed in 1 hour! Only Dynamiclear does this.

The study shows how the active in Dynamiclear instantly goes into action destroying the herpes virus colonies on contact, as well as the host cell harboring the virus. Dynamiclear acts like a spear, puncturing the host cell and the DNA of the herpes virus.

The result? The virus can’t multiply or spread and that puts the odds against the virus surviving or replicating. This information might help to explain why some people report fewer and less intense breakouts after each application of Dynamiclear.

Percentage of HSV cells inactivated after applying Dynamiclear active

Phase III Clinical Trial

In 2006 our company sponsored a comprehensive Phase 3 clinical trial to prove what we have witnessed for almost a decade - that Dynamiclear is a potent and very promising therapy for HSV-1 and HSV-2.

The Dynamiclear Phase III Clinical Trial was conducted on adult patients suffering from Herpes simplex infections Type I and Type II. It was a multicenter, randomized, prospective, open label study that has been conducted to evaluate the safety, tolerability and efficacy of Dynamiclear as a treatment for Herpes simplex (Type 1 and 2) in adult patients.

During the study, it was demonstrated that an application of Dynamiclear resulted in a significant reduction in symptoms after only one single application. There were no adverse events reported in this study.

In the clinical trial 33% of all users in the Dynamiclear group experienced complete healing of their HSV blisters 24 hours after a single application of Dynamiclear. After 48 hours a staggering 62% of all users had noticed complete disappearance of their blisters, compared to only 13% in the comparator control group.

By the end of the trial study period (7 days) 90% of Dynamiclear users were reported to have complete resolution of their blisters compared to just over half (53%) in the comparator group.

Dynamiclear Group vs Comparator Group

Gupta, S. , et al., (2006), “A Prospective, Randomized, Multi-center, Comparative, Open label study to Evaluate the Safety, Tolerability and Efficacy of Dynamiclear topical solution in patients suffering from Herpes Simplex Infection (HSV 1 & HSV 2) aged between 18 and 55 years.” SC/111/06; Version 07, 31 May 06


In all the efficacy parameters, including resolution of redness, burning, stinging, itching and blisters, a significantly higher percentage of patients in the Dynamiclear group were relieved of symptoms after a single application of the treatment by both ITT and PP analysis.

The study supports the safety and effectiveness of the Dynamiclear Antiviral Gel as a symptomatic antiviral remedy.

The Phase III trial on Dynamiclear was conducted by Apothecaries Ltd, an internationally recognized and independent Clinical Research Organization (CRO).

This study has been carried out in strict compliance with the ICH “Guidelines for Clinical Trials on Pharmaceutical Products” (GCP) issued by the Central Drugs Standard Control Organization for Phase III clinical trials, and is in accordance with the Ministry of Health and the ICMR guidelines for clinical trials.

The Dynamiclear Phase III clinical trial has been reviewed by a panel of experts, including an expert review by Professor John Quin who is Director of Clinical Immunology, Sexual Health and HIV Medicine at the Liverpool Hospital in Sydney Australia and Conjoint Associate Professor of Medicine at the University of NSW.

Read testimonies from Doctors and Pharmacists who use Dynamiclear.

© Dynamiclear Inc. 1997 - 2012. All Rights Reserved.